Metacrine Inc. (MTCR): Price and Financial Metrics

Metacrine Inc. (MTCR): $0.58

0.01 (-1.29%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

Add MTCR to Watchlist
Sign Up

MTCR Price/Volume Stats

Current price $0.58 52-week high $0.59
Prev. close $0.59 52-week low $0.30
Day low $0.58 Volume 83,800
Day high $0.59 Avg. volume 225,834
50-day MA $0.56 Dividend yield N/A
200-day MA $0.49 Market Cap 24.75M

MTCR Stock Price Chart Interactive Chart >


Metacrine Inc. (MTCR) Company Bio


Metacrine, Inc. is a clinical-stage biopharmaceutical company that engages in the discovery and development of differentiated therapies for patients with liver and gastrointestinal diseases. Its farnesoid X receptor, or FXR, is central to modulating liver and GI diseases. The company was founded by Ronald M. Evans, Richard A. Heyman, and Michael Downes in 2014 and is headquartered in San Diego, CA.


MTCR Latest News Stream


Event/Time News Detail
Loading, please wait...

MTCR Latest Social Stream


Loading social stream, please wait...

View Full MTCR Social Stream

MTCR Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!